Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment

Q Riller, C Cotteret, H Junot, N Benameur… - Journal of …, 2019 - Springer
Objectives Infliximab is increasingly used to treat neurosarcoidosis. We aimed to determine
the efficacy and tolerance of an infliximab biosimilar for treating neurosarcoidosis. Methods …
被引用次数：25 相关文章

Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment

Q Riller, C Cotteret, H Junot… - Journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Objectives Infliximab is increasingly used to treat neurosarcoidosis. We aimed to determine
the efficacy and tolerance of an infliximab biosimilar for treating neurosarcoidosis. Methods …

Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment

FC Aubart, Q Riller, C Cotteret, H Junot… - Journal of …, 2019 - hal.science
OBJECTIVES: Infliximab is increasingly used to treat neurosarcoidosis. We aimed to
determine the efficacy and tolerance of an infliximab biosimilar for treating neurosarcoidosis …

Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment.

Q Riller, C Cotteret, H Junot, N Benameur… - Journal of …, 2019 - search.ebscohost.com
Objectives: Infliximab is increasingly used to treat neurosarcoidosis. We aimed to determine
the efficacy and tolerance of an infliximab biosimilar for treating neurosarcoidosis. Methods …
[PDF] academia.edu

[PDF][PDF] Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment

Q Riller, C Cotteret, H Junot, N Benameur, J Haroche… - Evaluation, 2018 - academia.edu
Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective
study including switch from Page 1 Vol.:(0123456789) 1 3 Journal of Neurology https://doi.org/10.1007/s00415-019-09234-y …

Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment

Q Riller, C Cotteret, H Junot, N Benameur… - Journal of …, 2019 - search.proquest.com
Objectives Infliximab is increasingly used to treat neurosarcoidosis. We aimed to determine
the efficacy and tolerance of an infliximab biosimilar for treating neurosarcoidosis. Methods …

Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment

FC Aubart, Q Riller, C Cotteret, H Junot… - Journal of …, 2019 - hal.sorbonne-universite.fr
OBJECTIVES: Infliximab is increasingly used to treat neurosarcoidosis. We aimed to
determine the efficacy and tolerance of an infliximab biosimilar for treating neurosarcoidosis …

Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment.

Q Riller, C Cotteret, H Junot, N Benameur… - Journal of …, 2019 - europepmc.org
Objectives Infliximab is increasingly used to treat neurosarcoidosis. We aimed to determine
the efficacy and tolerance of an infliximab biosimilar for treating neurosarcoidosis. Methods …